Q1 2026 Holdings
Filed 2026-05-15 | 14 holdings | $722.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $294.5M | 9,198,900 | 40.8% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $84.2M | 4,644,386 | 11.7% |
| VOR Biopharma Inc(VOR) | COM NEW | 929033207 | $73.5M | 4,117,354 | 10.2% |
| Engene Holdings Inc(ENGN) | COM | 29286M105 | $65.6M | 9,632,561 | 9.1% |
| Maplight Therapeutics Inc(MPLT) | COM | 56565P103 | $65.6M | 3,226,400 | 9.1% |
| Damora Therapeutics Inc(GLTO) | COM NEW | 36322Q206 | $63.2M | 2,441,000 | 8.8% |
| Crescent Biopharma Inc.(CBIO) | COM | G2545C104 | $30.8M | 1,677,852 | 4.3% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $21.5M | 2,808,368 | 3.0% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $16.1M | 3,468,430 | 2.2% |
| Engene Holdings Inc(ENGNW) | W EXP 10/31/2028 | 29286M113 | $7.3M | 2,878,148 | 1.0% |